The use of leukocytes' secretome to individually target biological therapy in autoimmune arthritis: a case report.

Patrice E PoubelleNathalie PagéMarie-Pier LongchampsNatalia Sampaio MouraDavid B BeckIvona AksentijevichPhilippe A TessierMartin Pelletier

Published in: Clinical and translational medicine (2019)

An efficient way to effectively treat patients with complex autoimmune arthropathies, and avoid irreversible disability, is to know their leukocytes' secretome to identify abnormally secreted cytokines and personalize their biotherapy, as exemplified by this case report.

Keyphrases

multiple sclerosis
case report
peripheral blood
rheumatoid arthritis
drug induced
stem cells
mesenchymal stem cells